Managing the global burden of cardiovascular disease
Institute for International Health, Sydney, New South Wales, Australia
* Correspondence: Bruce Neal, Institute for International Health, University of Sydney, PO Box 576, Newtown, Sydney, NSW 2042, Australia.
Abstract
There is a large and increasing global burden of cardiovascular disease. Approximately 14 million individuals died of cardiovascular vasease in 1990, and this is projected to rise to about 25 million by 2020. In large part, this increase can be explained on the basis of major ongoing sociodemographic changes in developing countries, and associated effects on the numbers of individuals at risk and the levels of cardiovascular risk factors. Developing countries now experience a much greater burden of cardiovascular disease than do developed countries. In addition, developing countries are expected to experience the greatest rise in cardiovascular disease burden over the next few years. Cardiovascular disease prevention programmes designed and implemented primarily in developed countries have most likely averted much premature cardiovascular disease in those countries over the past few decades. However, cardiovascular disease prevention programmes designed for developed countries are unlikely to be directly transferable to developing countries. Reliable information to inform the design and implementation of cardiovascular disease prevention programmes, tailored to the socioeconomic circumstances of developing countries, is now required. Such programmes have great potential to impact on the current and projected global epidemic of cardiovascular disease.
Key Words: Cardiovascular disease burden • global